227 related articles for article (PubMed ID: 10763820)
21. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
22. Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells.
Bacus SS; Yarden Y; Oren M; Chin DM; Lyass L; Zelnick CR; Kazarov A; Toyofuku W; Gray-Bablin J; Beerli RR; Hynes NE; Nikiforov M; Haffner R; Gudkov A; Keyomarsi K
Oncogene; 1996 Jun; 12(12):2535-47. PubMed ID: 8700512
[TBL] [Abstract][Full Text] [Related]
23. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.
Li Y; Jenkins CW; Nichols MA; Xiong Y
Oncogene; 1994 Aug; 9(8):2261-8. PubMed ID: 7913544
[TBL] [Abstract][Full Text] [Related]
24. A mammalian in vitro centriole duplication system: evidence for involvement of CDK2/cyclin E and nucleophosmin/B23 in centrosome duplication.
Tarapore P; Okuda M; Fukasawa K
Cell Cycle; 2002 Jan; 1(1):75-81. PubMed ID: 12429912
[TBL] [Abstract][Full Text] [Related]
25. [Centrosome isolation from cultured bladder cancer cells--p53 mutation and centrosome hyperamplification].
Kawamura K; Moriyama M; Suga K; Shiba N; Tanaka T; Ikeda R; Suzuki K
Hinyokika Kiyo; 2003 Feb; 49(2):69-74. PubMed ID: 12696185
[TBL] [Abstract][Full Text] [Related]
26. Specific phosphorylation of nucleophosmin on Thr(199) by cyclin-dependent kinase 2-cyclin E and its role in centrosome duplication.
Tokuyama Y; Horn HF; Kawamura K; Tarapore P; Fukasawa K
J Biol Chem; 2001 Jun; 276(24):21529-37. PubMed ID: 11278991
[TBL] [Abstract][Full Text] [Related]
27. A cyclin-dependent kinase inhibitor (p21(WAF1/CIP1)) affects thymidine incorporation in human liver cancer cells.
Gong Y; Deng S; Zhang M; Wang G; Minuk GY; Burczynski F
Br J Cancer; 2002 Feb; 86(4):625-9. PubMed ID: 11870547
[TBL] [Abstract][Full Text] [Related]
28. Two for two: Cdk2 and its role in centrosome doubling.
Hinchcliffe EH; Sluder G
Oncogene; 2002 Sep; 21(40):6154-60. PubMed ID: 12214244
[No Abstract] [Full Text] [Related]
29. Sequential extension of proliferative lifespan in human fibroblasts induced by over-expression of CDK4 or 6 and loss of p53 function.
Morris M; Hepburn P; Wynford-Thomas D
Oncogene; 2002 Jun; 21(27):4277-88. PubMed ID: 12082615
[TBL] [Abstract][Full Text] [Related]
30. Centrosome duplication: three kinases come up a winner!
Hinchcliffe EH; Sluder G
Curr Biol; 2001 Sep; 11(17):R698-701. PubMed ID: 11553343
[TBL] [Abstract][Full Text] [Related]
31. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
Greider C; Chattopadhyay A; Parkhurst C; Yang E
Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
[TBL] [Abstract][Full Text] [Related]
32. WAF1/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis.
Kondo S; Barna BP; Kondo Y; Tanaka Y; Casey G; Liu J; Morimura T; Kaakaji R; Peterson JW; Werbel B; Barnett GH
Oncogene; 1996 Sep; 13(6):1279-85. PubMed ID: 8808702
[TBL] [Abstract][Full Text] [Related]
33. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
Rao S; Lowe M; Herliczek TW; Keyomarsi K
Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
[TBL] [Abstract][Full Text] [Related]
34. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
[TBL] [Abstract][Full Text] [Related]
35. High expression of cyclin E and G1 CDK and loss of function of p57KIP2 are involved in proliferation of malignant sporadic adrenocortical tumors.
Bourcigaux N; Gaston V; LogiƩ A; Bertagna X; Le Bouc Y; Gicquel C
J Clin Endocrinol Metab; 2000 Jan; 85(1):322-30. PubMed ID: 10634406
[TBL] [Abstract][Full Text] [Related]
36. Direct evidence for the role of centrosomally localized p53 in the regulation of centrosome duplication.
Shinmura K; Bennett RA; Tarapore P; Fukasawa K
Oncogene; 2007 May; 26(20):2939-44. PubMed ID: 17072342
[TBL] [Abstract][Full Text] [Related]
37. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
[TBL] [Abstract][Full Text] [Related]
38. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
[TBL] [Abstract][Full Text] [Related]
39. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
[TBL] [Abstract][Full Text] [Related]
40. Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells.
Bae I; Fan S; Bhatia K; Kohn KW; Fornace AJ; O'Connor PM
Cancer Res; 1995 Jun; 55(11):2387-93. PubMed ID: 7757991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]